Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
2.230
0.00 (0.00%)
At close: Nov 28, 2025, 1:00 PM EST
2.310
+0.080 (3.59%)
After-hours: Nov 28, 2025, 4:53 PM EST
Indaptus Therapeutics Market Cap
Indaptus Therapeutics has a market cap or net worth of $3.91 million as of November 28, 2025. Its market cap has decreased by -66.70% in one year.
Market Cap
3.91M
Enterprise Value
-1.91M
1-Year Change
-66.70%
Ranking
Category
Stock Price
$2.23
Market Cap Chart
Since August 4, 2021, Indaptus Therapeutics's market cap has decreased from $47.95M to $3.91M, a decrease of -91.86%. That is a compound annual growth rate of -44.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 3.91M | -61.40% |
| Dec 31, 2024 | 10.12M | -31.58% |
| Dec 29, 2023 | 14.79M | 21.38% |
| Dec 30, 2022 | 12.18M | -73.92% |
| Dec 31, 2021 | 46.70M | -2.60% |
| Aug 4, 2021 | 47.95M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 988.81B |
| Johnson & Johnson | 500.07B |
| AbbVie | 402.36B |
| UnitedHealth Group | 298.66B |
| AstraZeneca | 287.99B |
| Merck & Co. | 259.69B |
| Novartis AG | 249.49B |
| Abbott Laboratories | 223.51B |